/AMEUF
AMEUF Stock - Anteris Technologies Ltd
Healthcare|Medical - DevicesOTC
$5.70-35.81%
$3.18 (-35.81%) • Dec 26
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.27
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AMEUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.64 – $5.76
TARGET (TP)$6.55
STOP LOSS$5.24
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.75
52W High$15.53
52W Low$5.55
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.37M | $4.01M | $4.59M | $7.79M | $7.08M |
| Gross Profit | $2.05M | $2.52M | $2.61M | $6.15M | $4.36M |
| Gross Margin | 46.8% | 62.7% | 56.8% | 79.0% | 61.5% |
| Operating Income | $-126,625,640 | $-69,700,803 | $-44,942,327 | $-21,076,803 | $-17,200,470 |
| Net Income | $-123,263,368 | $-67,333,386 | $-44,340,161 | $-22,907,027 | $-15,274,534 |
| Net Margin | -2822.5% | -1678.0% | -966.0% | -294.0% | -215.8% |
| EPS | $-6.09 | $-4.31 | $-3.32 | $-3.09 | $-2.58 |
Company Overview
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AMEUFBeat Rate
0%
Last 1 quarters
Avg Surprise
-83.4%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-1.87
Q1 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q2 24
No data
Q4 24
-83.4%
$-1.83vs$-1.00
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Jul 29, 2025 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | — | $-1.87 | — | — |
Q4 2024 | Oct 31, 2024 | $-1.00 | $-1.83 | -83.4% | ✗ MISS |
Q2 2024 | May 29, 2024 | — | $-1.54 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-1.33 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-1.09 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-1.10 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-1.10 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-1.18 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-1.21 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.70 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.68 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-1.37 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-3.06 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-2.92 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-1.71 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-1.93 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-4.24 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-5.06 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-6.82 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AMEUF
What is AMEUF's current stock price?
Anteris Technologies Ltd (AMEUF) is currently trading at $5.70 per share. The stock has moved -35.81% today.
What is the analyst price target for AMEUF?
No analyst price targets are currently available for this stock.
What sector is Anteris Technologies Ltd in?
Anteris Technologies Ltd operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is AMEUF's market cap?
Anteris Technologies Ltd has a market capitalization of $0.12 billion, making it a small-cap company.
Does AMEUF pay dividends?
No, Anteris Technologies Ltd does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCKMTF
Carmat S.A.
$12.75
Mkt Cap: $0.1B
CMXC
Cell MedX Corp.
$0.42
Mkt Cap: $0.1B
COLRF
China Medical & HealthCare Group Limited
$0.08
Mkt Cap: $0.1B
COPHF
Creso Pharma Limited
$0.12
Mkt Cap: $0.1B
EPRXF
Eupraxia Pharmaceuticals Inc.
$3.04
Mkt Cap: $0.1B
GREH
Green Rain Energy Holdings Inc.
$0.00
Mkt Cap: $0.0B
JMDMF
Japan Medical Dynamic Marketing, Inc.
$3.01
Mkt Cap: $0.1B
LFLY
Leafly Holdings, Inc.
$37.00
Mkt Cap: $0.1B
PSTTF
Prescient Therapeutics Limited
$0.14
Mkt Cap: $0.1B
RSHUF
Respiri Limited
$0.06
Mkt Cap: $0.1B
Explore stocks similar to AMEUF for comparison